Nuzenio

Editas Medicine

Editas Medicine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 05:48:57 GMTWall Street Zen Upgrades Editas Medicine (NASDAQ:EDIT) to Hold - MarketBeat
Sat, 08 Aug 2026 03:45:24 GMTH.C. Wainwright Maintains Editas Medicine(EDIT.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Fri, 07 Aug 2026 22:13:01 GMTEditas Medicine director Ellinor Patrick Thomas II files initial beneficial ownership statement - Bitget
Fri, 07 Aug 2026 21:16:53 GMTEditas Medicine (NASDAQ: EDIT) grants director 103400 options at $2.9000 - Stock Titan
Fri, 07 Aug 2026 21:16:37 GMTEditas Medicine, Inc. (EDIT) director reports no share or option holdings - Stock Titan
Fri, 07 Aug 2026 04:57:04 GMTEditas Medicine (EDIT) Stock Rallies On Revenue Jump But Losses Linger - simplywall.st

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Editas Medicine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.